Research We Funded
Your generous support funds millions of dollars in research every year, in locations across the globe. From individual projects to global collaborations, we provide funding to experts in a variety of scientific focus areas critical to advancing the search for treatments and a cure for ALS.
Sampling of Grants We Have Funded During the Past 3 Years
| Grant ID | Project Title | Applicant | Award Start Date | Award End Date | Award Amount | Primary Organization | Program Name |
|---|---|---|---|---|---|---|---|
| 21-SI-569 | Maintain the SOD1 breeding colony in 2020 | Torvund-Jensen, Julie | 02/01/2020 | 01/31/2021 | 102600.00 | Taconic Biosciences, Inc. | Strategic Initiative |
| 21-MALS-568 | Eye Gaze Controlled Neck Brace for ALS Patients with Head Drop | Agrawal, Sunil | 02/01/2020 | 05/31/2023 | 200000.00 | The Trustees of Columbia University in the City of New York | Managing ALS - MALS |
| 20-SI-543 | Natural History Pilot Project-NU | Ajroud-Driss, Senda | 01/01/2020 | 06/30/2020 | 25659.00 | Northwestern University - Evanston Campus | Strategic Initiative |
| 22-PDF-609 | An Integrated Genome-Based Approach to Individualised Treatment in ALS and FTD | Al Khleifat, Ahmad | 01/31/2022 | 09/30/2023 | 150000.00 | King's College London, Institute of Psychiatry | Milton Safenowitz Postdoctoral Fellowship Program |
| 23-SI-621 | 2022 Holloway Postdoc Fellowship (AFTD/ALS Association) | Anderson, Eric | 07/01/2022 | 06/30/2024 | 60000.00 | University of Pittsburgh | Strategic Initiative |
| 20-MALS-555 | Development and usability of a neuromuscular wearable system to enable reliable caregiver alerts and communication for people with ALS | Ang, Dexter | 01/31/2020 | 07/31/2022 | 200000.00 | Pison Technology Inc | Managing ALS - MALS |
| 20-SI-561 | Natural History Pilot Project-Henry Ford Health | Arcila Londono, Ximena | 01/01/2020 | 09/30/2020 | 25659.00 | Henry Ford Health System | Strategic Initiative |
| 23-CSDA-618 | 2022 Clinician Scientist Development Award | Arnold, Frederick | 07/01/2022 | 06/30/2025 | 168000.00 | The Regents of the University of California (Irvine) | Clinician Scientist Development Award |
| 21-DDC-565 | Targeting soITNF-dependent inflammation in ALS with XPro1595 | Barnum, Christopher | 02/01/2020 | 10/31/2022 | 500000.00 | INmuneBio Inc. | The Lawrence and Isabel Barnett Drug Development Award |
| 20-DDC-548 | Targeting immune-checkpoint pathways: a novel therapeutic approach in ALS | Baruch, Kuti | 01/31/2020 | 07/31/2022 | 499413 | ImmunoBrain Checkpoint, Inc. | The Lawrence and Isabel Barnett Drug Development Award |
| 23-SI-622 | ALSUntangled | Bedlack, Richard | 07/01/2022 | 06/30/2025 | 66614.00 | Duke University | Strategic Initiative |
| 20-SI-563 | Renewal for 17-CPT-374, The Effects of RNS60 on ALS biomarkers | Beghi, Ettore | 01/01/2020 | 06/30/2021 | 283622.00 | Istituto di Ricerche Farmacologiche Mario Negri (Mario Negri Institute for Pharmacological Research) | Strategic Initiative |
| 20-IIA-530 | Using peripheral macrophages (PM) as a target for ALS | Boillee, Severine | 12/01/2019 | 03/31/2023 | 240000 | Paris Brain Institute (Institut du Cerveau - ICM), CNRS, Inria, Inserm, AP-HP, Sorbonne Université | Investigator-Initiated Multi-year Award |
| 20-SI-545 | Neurofilament levels in Cytokinetics Vitality Phase III Longitudinal Plasma Samples | Bowser, Robert | 01/31/2020 | 05/31/2022 | 154000.00 | Iron Horse Diagnostics, Inc. | Strategic Initiative |
| 22-SI-599 | The Answer ALS Research Data Portal | Boyce, Danielle | 09/01/2021 | 08/31/2023 | 620702.00 | Johns Hopkins University School of Medicine | Strategic Initiative |
| 22-CRTF-595 | Activity and Regulation of ALS Causing Variants of Kinesin KIF5A | Brent , Jonathan | 07/01/2021 | 06/30/2023 | 105000.00 | Northwestern Memorial Hospital | Clinical Research Training Fellow |
| 20-SI-562 | Trial of Dual Function, Gene Silencing-Replacement Therapy in Canine SOD1E40k/E40K ALS | Brown, Robert | 01/31/2020 | 06/30/2023 | 420000.00 | University of Massachusetts Chan Medical School | Strategic Initiative |
| 21-IIA-571 | Determining the Effects of Hexanucleotide Repeat Expansion on RNA Localization and Local Translation | Burguete, Alondra | 03/01/2020 | 11/30/2023 | 300000 | The Trustees of Columbia University in the City of New York | Investigator-Initiated Multi-year Award |
| 22-SI-612 | Development of skin biomarker for early diagnosis of ALS | Chen, Shu | 12/01/2021 | 11/30/2022 | 60000.00 | University of Alabama at Birmingham | Strategic Initiative |
| 21-DDC-574 | Copper-ATSM and follistatin: A nerve-muscle combination therapy strategy | Crouch, Peter | 04/01/2020 | 06/30/2022 | 495176 | University of Melbourne (Melbourne University) | The Lawrence and Isabel Barnett Drug Development Award |
| 20-SI-544 | Accelerating the Path to Effective Treatments for ALS-Platform Trial | Cudkowicz, Merit | 01/01/2020 | 12/31/2022 | 3000000 | The General Hospital Corporation doing business as Massachusetts General Hospital | Strategic Initiative |
| 20-SI-539 | The ALS Association Clinical Trial Support Program-MGH | Cudkowicz, Merit | 01/01/2020 | 12/31/2022 | 387658 | The General Hospital Corporation doing business as Massachusetts General Hospital | Strategic Initiative |
| 22-DDC-613 | GLP Studies on Antisense Oligonucleotide Therapies | Elbaum, Daniel | 01/31/2022 | 01/30/2024 | 500000.00 | QurAlis Corporation | The Lawrence and Isabel Barnett Drug Development Award |
| 22-SI-602 | ALS Drug Rescue using a Novel Machine-Learning Based Subgroup Analysis Tool | Ennist, David | 11/01/2021 | 01/31/2022 | 100000.00 | Origent Data Sciences, Inc. | Strategic Initiative |
| 20-IIA-540 | Identification of Novel Targets that Regulate Stress Granules and Rescue Neurodegeneration in ALS | Finkbeiner, Steve | 01/01/2020 | 06/30/2023 | 300000 | Gladstone Institutes | Investigator-Initiated Multi-year Award |
| 22-CTA-610 | RAPA-501 Hybrid TREG/Th2 Cell Therapy of ALS | Fowler, Daniel | 01/01/2022 | 12/31/2023 | 1000000.00 | Rapa Therapeutics, LLC | Clinical Trial Awards |
| 21-CRTF-577 | Feasibility and Patient/Caregiver Satisfaction of Telemedicine Visits for ALS Management | Ghasemia , Mehdi | 07/01/2020 | 06/30/2022 | 105000.00 | Massachusetts General Hospital (The General Hospital Corporation), Boston, MA | Clinical Research Training Fellow |
| 23-DDC-625 | TRPML1 small molecule agonists for the treatment of ALS | Gill, Martin | 10/01/2022 | 09/30/2024 | 450272.00 | Libra Therapeutics, Inc. | The Lawrence and Isabel Barnett Drug Development Award |
| 22-PDF-592 | Molecular mechanisms influencing cognitive impairment in C9orf72 ALS/FTD | Gittings, Lauren | 07/01/2021 | 06/30/2023 | 150000.00 | Dignity Health dba St. Joseph's Hospital & Medical Center, Phoenix, AZ | Milton Safenowitz Postdoctoral Fellowship Program |
| 20-IIA-532 | ALS Gene and Environment Interactions | Goutman, Stephen | 12/01/2019 | 11/30/2022 | 298676 | The Regents of the University of Michigan | Investigator-Initiated Multi-year Award |
| 20-MALS-549 | Maximizing Social Connection in Persons with Speech Impairment Due to ALS | Green, Jordan | 01/31/2020 | 07/31/2022 | 197087 | Massachusetts General Hospital-Institute of Health Professions | Managing ALS - MALS |
| 20-SI-542 | Natural History Pilot Project-VCU | Gwathmey, Kelly | 01/01/2020 | 03/31/2021 | 25659.00 | Virginia Commonwealth University | Strategic Initiative |
| 21-SI-570 | Natural History Pilot Project- St. Louis University | Hayat, Ghazala | 02/01/2020 | 09/30/2020 | 25659.00 | Saint Louis University | Strategic Initiative |
| 23-SGP-626 | Establishing an African ALS-research network to transform the ALS landscape | Heckmann, Jeannine | 10/01/2022 | 09/30/2023 | 50000.00 | University of Cape Town | Seed Grants Program |
| 21-SI-566 | Natural History Pilot Project- Temple University | Heiman-Patterson, Terry | 02/01/2020 | 12/31/2020 | 25659 | Temple University | Strategic Initiative |
| 20-IIA-524 | Microbiome in Progression of ALS | Hertzberg, Vicki | 11/01/2019 | 02/28/2024 | 299985.00 | Emory University | Investigator-Initiated Multi-year Award |
| 22-DDC-597 | Novel Protein Folding Gene Therapy for ALS | Hishiya, Akinori | 10/01/2021 | 09/30/2023 | 500000.00 | Sola Biosciences | The Lawrence and Isabel Barnett Drug Development Award |
| 20-MALS-553 | Enabling independent home use of an intracortical brain-computer interface for control of multiple communication devices | Hochberg, Leigh | 01/31/2020 | 06/29/2023 | 200000.00 | Brown University | Managing ALS - MALS |
| 21-SI-580 | Prognostic Value of miRNAs in biofluids from ALS patients | Hornstein, Eran | 10/01/2020 | 05/31/2022 | 50000.00 | Weizmann Institute of Science | Strategic Initiative |
| 22-CTA-614 | Repurposing Enoxacin therapy for patients with ALS | Hornstein, Eran | 01/01/2022 | 12/31/2023 | 750000.00 | Weizmann Institute of Science | Clinical Trial Awards |
| 22-SI-603 | Neurofilament as a Fluid Biomarker of Neurodegeneration in f-FTD Project | Horton, Wesley | 11/01/2021 | 10/31/2023 | 140000.00 | Foundation for the National Institutes of Health, Inc | Strategic Initiative |
| 20-IIA-529 | Countering the aggregation of TDP-43, FUS, DRPs, and Martin 3 with engineered protein disaggregases | Jackrel, Meredith | 11/01/2019 | 12/31/2023 | 300000.00 | Washington University in St.Louis | Investigator-Initiated Multi-year Award |
| 22-PDF-604 | Smartphone-based Digital Phenotyping in People with ALS | Johnson, Stephen | 10/01/2021 | 09/30/2022 | 75000.00 | Massachusetts General Hospital (Mass General) | Milton Safenowitz Postdoctoral Fellowship Program |
| 22-PDF-601 | Dysfunction and degeneration of corticospinal tract neurons in ALS mouse models | Kalambogias, John | 10/01/2021 | 09/30/2023 | 150000.00 | The Trustees of Columbia University in the City of New York | Milton Safenowitz Postdoctoral Fellowship Program |
| 21-SI-584 | Sleep, stress and Caregiving: Young Caregivers in ALS | Kavanaugh, Melinda | 12/01/2020 | 08/31/2022 | 28624.00 | University of Wisconsin-Milwaukee | Strategic Initiative |
| 21-SI-576 | Brainstorm BCT-002 US Biomarker Research | Kern, Ralph | 09/01/2020 | 05/31/2022 | 500000.00 | Brainstorm Cell Therapeutics, Inc | Strategic Initiative |
| 23-SEA-620 | 2022 Sheila Essey Award for ALS Research | Kiernan, Matthew | 07/01/2022 | 06/30/2023 | 50000.00 | Neuroscience Research Australia | Sheila Essey Award |
| 22-SI-600 | The role of circRNAs in the pathogenesis of motor neuron degeneration | King, Peter H. | 09/01/2021 | 08/31/2023 | 100000.00 | University of Alabama at Birmingham | Strategic Initiative |
| 21-PDF-582 | The mechanism by which loss of stathmin-2 induces neurodegeneration in ALS | Koike, Yuka | 01/31/2021 | 01/30/2023 | 150000.00 | Mayo Clinic Jacksonville | Milton Safenowitz Postdoctoral Fellowship Program |
| 21-CSDA-578 | Examining the role of ATM in selective vulnerability in ALS | Kreple , Collin | 07/01/2020 | 07/01/2022 | 168000.00 | Washington University in St.Louis | Clinician Scientist Development Award |
| 21-MALS-572 | A Mindful Community for People with ALS and their Primary Caregivers | Langer, Ellen | 03/01/2020 | 04/30/2023 | 200000.00 | President & Fellows of Harvard College | Managing ALS - MALS |
| 20-DDC-533 | Validation of Efficacy for an Inhibitor of TDP-43 Pathology in the DNLS Mouse Model of ALS | Larsen, Glenn | 12/01/2019 | 11/30/2020 | 194343 | Aquinnah Pharmaceuticals Inc | The Lawrence and Isabel Barnett Drug Development Award |
| 22-DDC-606 | Preclinical evaluation of bemcentinib as a novel therapeutic for ALS | Lee, Virginia | 01/15/2022 | 01/14/2024 | 500000.00 | Perelman School of Medicine, University of Pennsylvania | The Lawrence and Isabel Barnett Drug Development Award |
| 22-PDF-588 | Validating SYF2 suppression as a therapeutic strategy for diverse forms of ALS | Li, Yichen | 02/01/2021 | 01/31/2023 | 150000.00 | University of Southern California (USC) | Milton Safenowitz Postdoctoral Fellowship Program |
| 20-SI-537 | Natural History Pilot Project-NEMO | Lunetta, Christian | 01/01/2020 | 09/30/2020 | 25659.00 | Centro Clinico NEMO | Strategic Initiative |
| 21-PDF-564 | Unravelling shared molecular mechanisms in familial Amyotrophic Lateral Sclerosis | Marques, Christine | 02/01/2020 | 01/31/2022 | 100000.00 | The General Hospital Corporation doing business as Massachusetts General Hospital | Milton Safenowitz Postdoctoral Fellowship Program |
| 21-PDF-587 | Longitudinal cognition and behavior in presymptomatic ALS gene mutation carriers | McHutchison, Caroline | 01/31/2021 | 01/30/2023 | 148849.00 | University of Edinburgh | Milton Safenowitz Postdoctoral Fellowship Program |
| 21-SI-579 | Establishing the Natural History of Upper Motor Neurondominant ALS and PLS | Mitsumoto, Hiroshi | 08/01/2020 | 07/31/2023 | 220000.00 | The Trustees of Columbia University in the City of New York | Strategic Initiative |
| 20-IIA-531 | Identifying NK Cells as a Therapeutic Targets in ALS | Murdock, Benjamin | 12/01/2019 | 02/28/2023 | 300000 | The Regents of the University of Michigan | Investigator-Initiated Multi-year Award |
| 20-IIA-546 | Discovery of novel phenotypes of amyotrophic lateral sclerosis based on neurophysiological measures of network dysfunction for patient stratification in clinical trials | Nasseroleslami, Bahman | 01/01/2020 | 06/30/2023 | 300000 | The Provost, Fellows, Foundation Scholars, and the other members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin | Investigator-Initiated Multi-year Award |
| 20-SI-559 | HERV-K (HML-2) Suppression using Antiretroviral Therapy in Volunteers with ALS | Nath, Avindra | 01/01/2020 | 02/29/2024 | 348556 | National Institute of Neurological Disorders and Stroke, NIH NINDS | Strategic Initiative |
| 20-SI-547 | Natural History Pilot Project-Providence | Olney, Nicholas | 01/01/2020 | 09/30/2020 | 25659.00 | Providence Health and Services- Oregon dba Providence | Strategic Initiative |
| 22-PDF-605 | Pathomechanisms of ALS caused by SPTLC1 mutations | Pant, Devesh | 01/15/2022 | 01/14/2024 | 150000.00 | Emory University | Milton Safenowitz Postdoctoral Fellowship Program |
| 21-PDF-585 | Pathogenic mechanisms of ALS caused by KIF5A mutations | Parameswaran, Janani | 01/31/2021 | 01/30/2023 | 150000.00 | Emory University | Milton Safenowitz Postdoctoral Fellowship Program |
| 585-Closed | Pathogenic mechanisms of ALS caused by KIF5A mutations | Parameswaran, Janani | 01/31/2021 | 01/30/2023 | 0.00 | Emory University | Milton Safenowitz Postdoctoral Fellowship Program |
| 20-IIA-525 | Harnessing the heterogenity of neuroinflammatory responses to tackle neurodegeneration in Amyotrophic Lateral Sclerosis | Peviani, Marco | 12/01/2019 | 11/30/2022 | 276100 | Università di Pavia | Investigator-Initiated Multi-year Award |
| 20-DDC-550 | Preclinical evaluations of a novel small molecule Toll-Like 2 receptor (TLR2) antagonist as a putative ALS therapeutic | Price, Diana | 01/31/2020 | 04/30/2022 | 500000.00 | Neuropore Therapies, Inc | The Lawrence and Isabel Barnett Drug Development Award |
| 23-PDF-623 | Applying the human disaggregase, HtrA1, to counter Amyotrophic Lateral Sclerosis | PURI, ANURADHIKA | 08/01/2022 | 07/31/2024 | 150000.00 | Washington University in St.Louis | Milton Safenowitz Postdoctoral Fellowship Program |
| 20-SI-536 | TDP43 Biomarker Initiative | Raisinghani, Manish | 01/01/2020 | 04/30/2021 | 350000 | Target ALS Foundation | Strategic Initiative |
| 20-DDC-551 | Pre-clinical development of a Live Biotherapeutic Product used in the treatment of ALS | Reyes, Christopher | 01/31/2020 | 01/30/2022 | 500000 | Bloom Science Co | The Lawrence and Isabel Barnett Drug Development Award |
| 22-CTA-615 | Target NMJ to maintain motor functions in ALS | Robitaille, Richard | 01/30/2022 | 01/29/2025 | 996938.06 | Université de Montréal | Clinical Trial Awards |
| 21-SI-581 | Development of ALS genetic testing guidelines | Roggenbuck, Jennifer | 12/01/2020 | 06/30/2022 | 149188.00 | The Ohio State University | Strategic Initiative |
| 20-PDF-527 | C9ORF72: Endobody vaccine for the treatment of C9 ALS/FTD | Romano, Lisa | 11/01/2019 | 10/31/2021 | 100000.00 | University of Florida | Milton Safenowitz Postdoctoral Fellowship Program |
| 22-DDC-608 | ASO mediated knockdown of CHMP7 as a novel therapeutic strategy for ALS/FTD | Rothstein, Jeffrey | 01/01/2022 | 12/31/2023 | 494444.00 | Johns Hopkins University School of Medicine | The Lawrence and Isabel Barnett Drug Development Award |
| 21-SEA-575 | Sheila Essey Award 2020 | Rouleau , Guy | 05/21/2020 | 05/20/2021 | 50000.00 | Montreal Neurological Hospital and Institute | Sheila Essey Award |
| 22-CSDA-594 | Lysosomal Protease Dysfunction in Amyotrophic Lateral Sclerosis | Sampognaro, Paul | 07/01/2021 | 06/30/2024 | 168000.00 | The Regents of the University of California, San Francisco | Clinician Scientist Development Award |
| 21-SI-573 | Renewal for 16-LGCA-311, Integrated genomics in clinical AKS: PBMC library generation | Sareen, Dhruv | 03/01/2020 | 03/31/2021 | 39990 | Cedars-Sinai Medical Center | Strategic Initiative |
| 22-DDC-607 | Antagonism of RAGE/DIAPH1 and Therapies for Amyotrophic Lateral Sclerosis | Schmidt, Ann Marie | 01/01/2022 | 12/31/2023 | 500000.00 | New York University Grossman School of Medicine | The Lawrence and Isabel Barnett Drug Development Award |
| 22-PDF-590 | Ten finger typing using an intra-cortical implant for fast communication in ALS | Shah, Nishal | 02/01/2021 | 01/31/2023 | 150000.00 | The Board of Trustees of the Leland Stanford Junior University | Milton Safenowitz Postdoctoral Fellowship Program |
| 20-SI-552 | The ALS Association Clinical Trial Support Program-BNI | Shefner, Jeremy | 01/01/2020 | 12/31/2022 | 264885 | Dignity Health dba St. Joseph's Hospital & Medical Center, Phoenix, AZ | Strategic Initiative |
| 23-CRTF-619 | 2022 Clinical Research Training Scholarship | Shellikeri, Sanjana | 07/01/2022 | 06/30/2024 | 105000.00 | Perelman School of Medicine, University of Pennsylvania | Clinical Research Training Fellow |
| 20-SI-535 | ALS Focus Platform | Sherman, Alexander | 01/01/2020 | 06/30/2021 | 304669.00 | The General Hospital Corporation doing business as Massachusetts General Hospital | Strategic Initiative |
| 20-SI-541 | Natural History Pilot Project-MGH | Sherman, Alexander | 01/01/2020 | 06/30/2020 | 44240 | The General Hospital Corporation doing business as Massachusetts General Hospital | Strategic Initiative |
| 21-SI-567 | The Pooled Resource Open Access ALS Clinical Trials (Pro-Act) Database | Sherman, Alexander | 02/01/2020 | 01/31/2023 | 1262129 | The General Hospital Corporation doing business as Massachusetts General Hospital | Strategic Initiative |
| 22-SI-596 | ALS FOCUS Program, Surveys, Maintenance, and Support | Sherman, Alexander | 07/01/2021 | 08/31/2023 | 263050.00 | Massachusetts General Hospital (Mass General) | Strategic Initiative |
| 20-SI-557 | Expanded Access to the FUS-ASO, Jacifusen for the Treatment of Mutant FUS-Associated ALS | Shneider, Neil | 01/01/2020 | 12/31/2022 | 650000.00 | The Trustees of Columbia University in the City of New York | Strategic Initiative |
| 20-IIA-534 | Antagonizing neurotoxic phase transitions of TDP-43 and FUS with small RNA therapeutics | Shorter, James | 12/01/2019 | 02/28/2023 | 300000 | The Trustees of the University of Pennsylvania | Investigator-Initiated Multi-year Award |
| 20-MALS-554 | Respiratory Health Management in Amytrophic Lateral Sclerosis through Telemonitoring and Nurse Health Coaching | Simmons, Zachary | 01/31/2020 | 07/31/2023 | 197302.00 | The Pennsylvania State University | Managing ALS - MALS |
| 22-CTA-611 | Acute adenosine receptor antagonism to promote breathing plasticity in ALS | Smith, Barbara | 01/01/2022 | 12/31/2024 | 880826.00 | University of Florida | Clinical Trial Awards |
| 22-PDF-591 | Family-based self-compassion intervention for reducing self-stigma in ALS | Sommers-Spijkerman, Marion | 07/01/2021 | 06/30/2023 | 150000.00 | University Medical Center Utrecht | Milton Safenowitz Postdoctoral Fellowship Program |
| 23-SI-616 | Establishing causative roles for SARM1 coding & expression level variants in ALS | Sreedharan, Jemeen | 03/01/2022 | 08/31/2024 | 400000.00 | King's College London, Institute of Psychiatry | Strategic Initiative |
| 21-SI-586 | Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for ALS | STAFF, NATHAN | 01/31/2021 | 12/31/2023 | 252000.00 | Mayo Clinic Rochester | Strategic Initiative |
| 22-DDC-598 | Development of a matrix metalloproteinase inhibitor for the treatment of ALS | Sucholeiki, Irving | 10/01/2021 | 07/31/2023 | 500000.00 | Aquilus Pharmaceuticals, Inc. | The Lawrence and Isabel Barnett Drug Development Award |
| 22-SI-589 | Maintain the SOD1 breeding colony in 2021 | Torvund-Jensen, Julie | 02/01/2021 | 01/31/2022 | 145800.00 | Taconic Biosciences, Inc. | Strategic Initiative |
| 23-SI-617 | Maintain the SOD1 breeding colony in 2022 | Torvund-Jensen, Julie | 02/01/2022 | 01/31/2023 | 343410.00 | Taconic Biosciences, Inc. | Strategic Initiative |
| 20-IIA-526 | ALS Patient Progression Tracking Mobile App vs Clinical Data Collection | Tyler, Chris | 12/01/2019 | 11/30/2022 | 300000 | ALS Never Surrender Foundation | Investigator-Initiated Multi-year Award |
| 21-PDF-583 | Determining mechanisms of TDP-43 liquid-liquid phase separation and aggregation | Vazquez-Sanchez, Sonia | 01/31/2021 | 01/30/2023 | 150000.00 | Ludwig Instituite for Cancer Research | Milton Safenowitz Postdoctoral Fellowship Program |
| 22-SEA-593 | Sheila Essey Award 2021 | Veldink, Jan | 04/21/2021 | 04/20/2022 | 50000.00 | University Medical Center Utrecht | Sheila Essey Award |
| 20-SI-558 | Natural History Pilot Project- University of Minnesota | WALK, DAVID | 01/01/2020 | 10/31/2020 | 25659.00 | Regents of the University of Minnesota - Twin Cities | Strategic Initiative |
| 20-MALS-538 | Eye gaze-based technology using Apple TrueDepth camera to enable communication for ALS patients | Wang, Fusheng | 01/31/2020 | 07/31/2022 | 199998 | State University of New York, Stony Brook | Managing ALS - MALS |
| 20-SI-560 | Natural History Pilot Project- University of Florida | Wymer, James | 01/01/2020 | 06/30/2020 | 25659.00 | University of Florida | Strategic Initiative |
| 20-IIP-556 | Developing Chemically Induced Senescence to Model ALS Pathogenesis Using iPSCs | Zhang, Su Chun | 01/31/2020 | 04/30/2021 | 50000.00 | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Investigator-Initiated Starter Award |